Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution.
Sebastian de ArmasCarolina Huertas-AyalaRandall Y ChanYueh-Yun ChiWinston W HuhAmanda TermuhlenPaul S GaynonAlexandra E KovachAndrew DoanPublished in: Pediatric blood & cancer (2022)
ABVD and ABVE-PC achieved similar survival outcomes in our single-institution cohort.